Moderna announced Tuesday it is filing for full U.S. Food and Drug Administration (FDA) approval of its COVID-19 vaccine.
Right now, the vaccine is only authorized for emergency use.
Full approval would allow Moderna to market the vaccine directly. Approval could also help curb vaccine hesitancy.
Moderna said it will submit data to the FDA on a rolling basis over the coming weeks. The FDA will tell Moderna when their data has been accepted for review.
Pfizer sought full approval for its vaccine last month.
Gwen Baumgardner: WE’VE GOT BREAKING NEWS ABOUT MODERNA’S COVID VACCINE.
I’M GWEN BAUMGARDNER WITH STRAIGHT ARROW NEWS.
THIS MORNING — MODERNA ANNOUNCED IT IS SEEKING FULL U-S APPROVAL FOR ITS COVID-19 VACCINE.
RIGHT NOW — THE VACCINE IS ONLY AUTHORIZED FOR EMERGENCY USE IN THE U-S.
FULL APPROVAL WOULD ALLOW MODERNA TO MARKET THE VACCINE DIRECTLY.
MODERNA SAYS IT WILL SUBMIT DATA TO THE F-D-A OVER THE COMING WEEKS…TO START THE APPROVAL PROCESS.
LAST MONTH — PFIZER ANNOUNCED IT WAS SEEKING THE SAME FULL APPROVAL OF ITS VACCINE.
FOR MORE BREAKING NEWS THROUGHOUT THE DAY — STICK WITH STRAIGHT ARROW NEWS DOT COM.